Sharemaestro Newsreel

Thermo Fisher Scientific (TMO) Launches Gibco CHO K1 Panel On A Fair Value Question

Thermo Fisher Scientific (TMO) has introduced the Gibco CHO-K1 Catalog Panel, a cGMP-ready media portfolio aimed at improving cell growth, protein yield, and workflow flexibility for biologics and biosimilars developers. Thermo Fisher Scientific sits at US$665.30 per share after a 30-day share price return …

Thermo Fisher Scientific (TMO) Rolls Out New Media Panel For Biologics Development

Thermo Fisher Scientific (NYSE:TMO) has introduced the Gibco CHO-K1 Catalog Panel, a new off the shelf media offering for biologics developers. The panel includes cGMP ready, chemically defined, animal origin free basal and feed media aimed at broad process development and manufacturing use. The …

Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development

New cGMP-ready media and feed panel helps developers rapidly identify high-performing combinations, with study results demonstrating up to 73% higher titer versus benchmark catalog media and feeds and up to 202% higher peak viable cell density compared with benchmark products tested Key facts Product: …

Capitalize on High Content Screening Disruption: Decode How Thermo Fisher Scientific, Danaher, Revvity, and Yokogawa Are Reshaping Global R&D ROI and Revenue

Company Logo High-content screening is advancing drug discovery and personalized medicine, driven by 3D models, advanced imaging and automated analytics, with opportunities in cancer research and organoids. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "High Content Screening (HCS) - Global Strategic Business Report" has …

Capitalize on the High Throughput Screening Shift: Track Thermo Fisher, Agilent, Danaher, Revvity and Tecan as AI-Driven Drug Discovery Reshapes R&D ROI

Company Logo AI, automation, robotics, microfluidics and nanotechnology are advancing HTS, while personalized medicine, biologics, research funding and pharma-academia partnerships drive demand. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "High Throughput Screening (HTS) - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. …

¿Está la revisión al alza de las previsiones modificando el argumento de inversión de las acciones de Thermo Fisher (TMO)?

Thermo Fisher Scientific (TMO) is Positioned for Resurgence

Fenimore Asset Management, an investment management company, released its Q2 2026 investor letter. You can download the letter here. U.S. equity markets saw broad gains in Q2, driven by strong corporate earnings, economic resilience, and enthusiasm for artificial intelligence (AI). Major indices reached all-time …

Three Analysts, Three Verdicts on Thermo Fisher: Here’s Who the Numbers Favor

Three Analysts, Three Verdicts on Thermo Fisher: Here's Who the Numbers Favor ©TIKR Key Stats for Thermo Fisher Stock Current Price: $641.39 Target Price (Mid): ~$839 Street Target: ~$645 Potential Total Return: ~31% Annualized IRR: ~7% / year What Happened? Thermo Fisher Scientific (TMO) …

Why Is Thermo Fisher Scientific (TMO) Building A Massive Early Disease Data Platform?

Thermo Fisher Scientific (NYSE:TMO) and Mayo Clinic announced the formation of Precure, LLC for early disease detection using multi omic data. Precure plans to integrate proteomic, genomic, and longitudinal clinical records into a single biomedical dataset to identify early disease signals. The collaboration positions …

Thermo Fisher Sees Stronger Demand, Calls 2026 an ‘Outstanding Year’

Key Points Interested in Thermo Fisher Scientific Inc.? Here are five stocks we like better. Thermo Fisher raised its outlook after returning to 5% organic growth in the second quarter, with adjusted EPS up 13%. CEO Marc Casper expects about 4% organic growth in …

Mayo Clinic and Thermo Fisher Scientific launch Precure, LLC to identify signs of disease before symptoms appear

Pioneering initiative will generate data at the frontier of healthcare to help transform early biological signals into new opportunities for prevention, diagnosis and treatment ROCHESTER, Minn. and WALTHAM, Mass., Sept. 15, 2026 /PRNewswire/ -- Mayo Clinic today announced the launch of Precure, LLC, with …

¿Está Thermo Fisher Scientific (TMO) Cara Tras Lanzar Multiskan Ease?

Analysts See Thermo Fisher at $748 Here’s Where the Stock Could Go

Thermo Fisher Drew Two Upgrades Near Its Highs. Here’s Where the Stock Could Go

Thermo Fisher, Danaher Could Log Mid-Single-Digit Organic Revenue Growth in 2027, UBS Says

Thermo Fisher Scientific (TMO) and Danaher (DHR) are likely to return to mid-single-digit organic re PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have …

Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls

Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 …

UBS Upgrades Thermo Fisher Scientific to Buy From Neutral, Adjusts Price Target to $730 From $540

Should You Continue to Hold TMO Stock in Your Portfolio?

Thermo Fisher Scientific Inc.'s TMO growth continues to benefit from a broader pickup in customer activity. The company is using acquisitions to move deeper into some of the more attractive corners of the life sciences market while strengthening ties with customers. At the same …

Las acciones de Thermo Fisher Scientific (TMO) parecen estar cerca de su valor razonable tras una subida del 24 %

TMO Stock Could Gain Following the Launch of EMPAD G2 Detector

Thermo Fisher Scientific Inc. TMO recently unveiled the Thermo Scientific EMPAD G2 detector to help researchers analyze materials in unprecedented detail. This development is expected to bolster the company's Analytical Instruments segment. TMO Stock Outlook Following the News After the announcement, TMO shares dipped …

Thermo Fisher Scientific to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026

WALTHAM, Mass., September 01, 2026--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman and chief executive officer, will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026 at …

Thermo Fisher Scientific (TMO) Unveils New Tools For Electron Microscopy And Isotope Analysis

Thermo Fisher Scientific (NYSE:TMO) introduces the EMPAD G2 detector for high speed, high dynamic range 4D scanning transmission electron microscopy. The company launches Orbitrap Isora and Isora Pro Mass Spectrometers that integrate molecular level isotope ratio analysis. The new instruments target research in material …

Thermo Fisher Is Up 23% in a Year. Is It Too Late to Buy at $622?

Thermo Fisher vs. Intuitive Surgical: Which Premium Healthcare Stock Deserves its Valuation?

Premium healthcare stocks often trade at elevated valuations for very different reasons. Thermo Fisher's (NYSE:TMO) investment case increasingly depends on whether the life sciences industry is emerging from its post-pandemic slowdown, while Intuitive Surgical (NASDAQ:ISRG) continues to hold a dominant position in robotic surgery …

Thermo Fisher Has Rallied 45% Off Its Lows to Near a 52-Week High. Is It Too Late to Buy?

Thermo Fisher Scientific (TMO) Could Be Fully Valued On Parkinsons Proteomics Progress

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Thermo Fisher Scientific (TMO) is drawing investor attention after completing Olink Explore HT proteomic analysis on about 5,500 samples from The Michael J. Fox Foundation's Parkinson's Precision …

Thermo Fisher Scientific (TMO) Stock Fair Value Rises After Q2 Strength And Analyst Revisions

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. The latest analyst work on Thermo Fisher Scientific includes a higher Fair Value Estimate that has moved from US$590.77 to US$631.42, a change …

Thermo Fisher (TMO) Stock Looks Fully Valued Following Its Microbiology Sale

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Thermo Fisher Scientific stock has delivered a strong 26.3% return over the past year, yet the valuation checks suggest the shares are no …

THERMO FISHER SCIENTIFIC, INC.

XPO names chief legal officer

This story was originally published on Trucking Dive. To receive daily news and insights, subscribe to our free daily Trucking Dive newsletter. XPO appointed Jonas Svedlund chief legal officer, according to an Aug. 10 press release. Svedlund, whose appointment was effective immediately, most recently …

Q2 Earnings Highs And Lows: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks

Q2 Earnings Highs And Lows: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks The end of the earnings season is always a good time to take a step back and see who shined (and who didn't). Let's take a …

El presidente y director ejecutivo de Thermo Fisher vende acciones por 8,6 millones de dólares

Envetec Appoints Patrick S. Jones as Independent Director

Envetec Senior Thermo Fisher Scientific executive brings nearly 30 years of healthcare and commercial leadership to support Envetec's global expansion Patrick S. JonesPatrick S. Jones, President of Thermo Fisher Scientific's Clinical Diagnostics Division and independent director of Envetec Sustainable Technologies BIRDHILL, Ireland, Aug. 14, …